Want to see JP:4583 full AI Analyst Report?
Cba-1535, Cba-1535+Pembrolizumab
Solid Tumors, Refractory Cancer
Phase I
Recruiting
A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.
Apr 07, 2025
―
Cba-1205 Part 1, Cba-1205 Part 2, Cba-1205 Part 3, Cba-1205 Part 4, Cba-1205 Part 5
Solid Tumors, Malignant Melanoma, Hepatocellular Carcinoma (Hcc), Pediatric Cancer
Phase I
Recruiting
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
Sep 30, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Chiome Bioscience Inc. (4583) have in its pipeline
4583 is currently developing the following drugs: Cba-1535, Cba-1535+Pembrolizumab, Cba-1205 Part 1, Cba-1205 Part 2, Cba-1205 Part 3, Cba-1205 Part 4, Cba-1205 Part 5. These drug candidates are in various stages of clinical development as the company works toward FDA approval.